Old and new members of GRK 2381 after the Science Seminar on July 2, 2025 in the IFIB courtyard. The project leaders and the 3rd cohort of doctoral students welcome the new young researchers of the 4th cohort.
The first GRK 2381 doctoral students arrived in Boston (January 15, 2022)
In this Research Training Group ("Graduiertenkolleg" 2381, GRK 2381) entitled "cGMP: From Bedside to Bench", doctoral researchers investigate the second messenger cyclic guanosine monophosphate (cGMP). cGMP is responsible for the transmission of signals in cells, and many drugs for the treatment of cardiovascular diseases target this signaling pathway. The latest findings suggest that cGMP-modulating drugs can be used even more widely. This will be investigated by the junior scientists of the GRK 2381.